nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—Productive cough—Telbivudine—hepatitis B	0.0947	0.0947	CcSEcCtD
Glycopyrrolate—Musculoskeletal chest pain—Telbivudine—hepatitis B	0.049	0.049	CcSEcCtD
Glycopyrrolate—Urinary hesitation—Lamivudine—hepatitis B	0.0261	0.0261	CcSEcCtD
Glycopyrrolate—Pregnancy—Lamivudine—hepatitis B	0.0189	0.0189	CcSEcCtD
Glycopyrrolate—Anaphylactoid reaction—Entecavir—hepatitis B	0.0173	0.0173	CcSEcCtD
Glycopyrrolate—Pain in extremity—Telbivudine—hepatitis B	0.0138	0.0138	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Entecavir—hepatitis B	0.0135	0.0135	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Entecavir—hepatitis B	0.0131	0.0131	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Telbivudine—hepatitis B	0.0123	0.0123	CcSEcCtD
Glycopyrrolate—Abdominal distension—Telbivudine—hepatitis B	0.012	0.012	CcSEcCtD
Glycopyrrolate—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0118	0.0118	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Telbivudine—hepatitis B	0.0114	0.0114	CcSEcCtD
Glycopyrrolate—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0112	0.0112	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0111	0.0111	CcSEcCtD
Glycopyrrolate—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0111	0.0111	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0111	0.0111	CcSEcCtD
Glycopyrrolate—Mental disorder—Entecavir—hepatitis B	0.0102	0.0102	CcSEcCtD
Glycopyrrolate—Malnutrition—Entecavir—hepatitis B	0.0101	0.0101	CcSEcCtD
Glycopyrrolate—Photophobia—Lamivudine—hepatitis B	0.0101	0.0101	CcSEcCtD
Glycopyrrolate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00986	0.00986	CcSEcCtD
Glycopyrrolate—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00972	0.00972	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Telbivudine—hepatitis B	0.00949	0.00949	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Telbivudine—hepatitis B	0.00938	0.00938	CcSEcCtD
Glycopyrrolate—Gastroenteritis—Lamivudine—hepatitis B	0.00877	0.00877	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Telbivudine—hepatitis B	0.0086	0.0086	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00855	0.00855	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00834	0.00834	CcSEcCtD
Glycopyrrolate—Malnutrition—Telbivudine—hepatitis B	0.00831	0.00831	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Entecavir—hepatitis B	0.00825	0.00825	CcSEcCtD
Glycopyrrolate—Infection—Entecavir—hepatitis B	0.0082	0.0082	CcSEcCtD
Glycopyrrolate—Dysgeusia—Telbivudine—hepatitis B	0.00813	0.00813	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Entecavir—hepatitis B	0.00809	0.00809	CcSEcCtD
Glycopyrrolate—Skin disorder—Entecavir—hepatitis B	0.00801	0.00801	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00789	0.00789	CcSEcCtD
Glycopyrrolate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00782	0.00782	CcSEcCtD
Glycopyrrolate—Affect lability—Lamivudine—hepatitis B	0.00765	0.00765	CcSEcCtD
Glycopyrrolate—Insomnia—Entecavir—hepatitis B	0.00746	0.00746	CcSEcCtD
Glycopyrrolate—Mood swings—Lamivudine—hepatitis B	0.00736	0.00736	CcSEcCtD
Glycopyrrolate—Somnolence—Entecavir—hepatitis B	0.00734	0.00734	CcSEcCtD
Glycopyrrolate—Dyspepsia—Entecavir—hepatitis B	0.00726	0.00726	CcSEcCtD
Glycopyrrolate—Dehydration—Lamivudine—hepatitis B	0.00723	0.00723	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00712	0.00712	CcSEcCtD
Glycopyrrolate—Fatigue—Entecavir—hepatitis B	0.00711	0.00711	CcSEcCtD
Glycopyrrolate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00709	0.00709	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00702	0.00702	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00695	0.00695	CcSEcCtD
Glycopyrrolate—Nasopharyngitis—Lamivudine—hepatitis B	0.00695	0.00695	CcSEcCtD
Glycopyrrolate—Abdominal distension—Lamivudine—hepatitis B	0.00676	0.00676	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Entecavir—hepatitis B	0.00675	0.00675	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Telbivudine—hepatitis B	0.00665	0.00665	CcSEcCtD
Glycopyrrolate—Skin disorder—Telbivudine—hepatitis B	0.00658	0.00658	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00658	0.00658	CcSEcCtD
Glycopyrrolate—Abdominal pain—Entecavir—hepatitis B	0.00652	0.00652	CcSEcCtD
Glycopyrrolate—Body temperature increased—Entecavir—hepatitis B	0.00652	0.00652	CcSEcCtD
Glycopyrrolate—Abdominal discomfort—Lamivudine—hepatitis B	0.00644	0.00644	CcSEcCtD
Glycopyrrolate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00636	0.00636	CcSEcCtD
Glycopyrrolate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00636	0.00636	CcSEcCtD
Glycopyrrolate—Dysuria—Lamivudine—hepatitis B	0.00628	0.00628	CcSEcCtD
Glycopyrrolate—Insomnia—Telbivudine—hepatitis B	0.00613	0.00613	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Lamivudine—hepatitis B	0.00606	0.00606	CcSEcCtD
Glycopyrrolate—Dyspepsia—Telbivudine—hepatitis B	0.00597	0.00597	CcSEcCtD
Glycopyrrolate—Asthenia—Entecavir—hepatitis B	0.00592	0.00592	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00585	0.00585	CcSEcCtD
Glycopyrrolate—Fatigue—Telbivudine—hepatitis B	0.00584	0.00584	CcSEcCtD
Glycopyrrolate—Pain—Telbivudine—hepatitis B	0.0058	0.0058	CcSEcCtD
Glycopyrrolate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00578	0.00578	CcSEcCtD
Glycopyrrolate—Sweating—Lamivudine—hepatitis B	0.00574	0.00574	CcSEcCtD
Glycopyrrolate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.0057	0.0057	CcSEcCtD
Glycopyrrolate—Epistaxis—Lamivudine—hepatitis B	0.00565	0.00565	CcSEcCtD
Glycopyrrolate—Sinusitis—Lamivudine—hepatitis B	0.00562	0.00562	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Telbivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Telbivudine—hepatitis B	0.00554	0.00554	CcSEcCtD
Glycopyrrolate—Dizziness—Entecavir—hepatitis B	0.00546	0.00546	CcSEcCtD
Glycopyrrolate—Rhinitis—Lamivudine—hepatitis B	0.00539	0.00539	CcSEcCtD
Glycopyrrolate—Abdominal pain—Telbivudine—hepatitis B	0.00536	0.00536	CcSEcCtD
Glycopyrrolate—Body temperature increased—Telbivudine—hepatitis B	0.00536	0.00536	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Lamivudine—hepatitis B	0.00535	0.00535	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Lamivudine—hepatitis B	0.00528	0.00528	CcSEcCtD
Glycopyrrolate—Vomiting—Entecavir—hepatitis B	0.00525	0.00525	CcSEcCtD
Glycopyrrolate—Rash—Entecavir—hepatitis B	0.0052	0.0052	CcSEcCtD
Glycopyrrolate—Dermatitis—Entecavir—hepatitis B	0.0052	0.0052	CcSEcCtD
Glycopyrrolate—Headache—Entecavir—hepatitis B	0.00517	0.00517	CcSEcCtD
Glycopyrrolate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00512	0.00512	CcSEcCtD
Glycopyrrolate—Rash—Adefovir Dipivoxil—hepatitis B	0.00508	0.00508	CcSEcCtD
Glycopyrrolate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00507	0.00507	CcSEcCtD
Glycopyrrolate—Headache—Adefovir Dipivoxil—hepatitis B	0.00504	0.00504	CcSEcCtD
Glycopyrrolate—Nausea—Entecavir—hepatitis B	0.0049	0.0049	CcSEcCtD
Glycopyrrolate—Asthenia—Telbivudine—hepatitis B	0.00486	0.00486	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Lamivudine—hepatitis B	0.00485	0.00485	CcSEcCtD
Glycopyrrolate—Pruritus—Telbivudine—hepatitis B	0.0048	0.0048	CcSEcCtD
Glycopyrrolate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00478	0.00478	CcSEcCtD
Glycopyrrolate—Erythema—Lamivudine—hepatitis B	0.00468	0.00468	CcSEcCtD
Glycopyrrolate—Malnutrition—Lamivudine—hepatitis B	0.00468	0.00468	CcSEcCtD
Glycopyrrolate—Flatulence—Lamivudine—hepatitis B	0.00461	0.00461	CcSEcCtD
Glycopyrrolate—Tension—Lamivudine—hepatitis B	0.00459	0.00459	CcSEcCtD
Glycopyrrolate—Dysgeusia—Lamivudine—hepatitis B	0.00458	0.00458	CcSEcCtD
Glycopyrrolate—Nervousness—Lamivudine—hepatitis B	0.00455	0.00455	CcSEcCtD
Glycopyrrolate—Dizziness—Telbivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Glycopyrrolate—Vomiting—Telbivudine—hepatitis B	0.00431	0.00431	CcSEcCtD
Glycopyrrolate—Rash—Telbivudine—hepatitis B	0.00427	0.00427	CcSEcCtD
Glycopyrrolate—Dermatitis—Telbivudine—hepatitis B	0.00427	0.00427	CcSEcCtD
Glycopyrrolate—Headache—Telbivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Glycopyrrolate—Convulsion—Lamivudine—hepatitis B	0.00406	0.00406	CcSEcCtD
Glycopyrrolate—Nausea—Telbivudine—hepatitis B	0.00403	0.00403	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00396	0.00396	CcSEcCtD
Glycopyrrolate—Dry mouth—Lamivudine—hepatitis B	0.0039	0.0039	CcSEcCtD
Glycopyrrolate—Confusional state—Lamivudine—hepatitis B	0.00385	0.00385	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Lamivudine—hepatitis B	0.00382	0.00382	CcSEcCtD
Glycopyrrolate—Oedema—Lamivudine—hepatitis B	0.00382	0.00382	CcSEcCtD
Glycopyrrolate—Infection—Lamivudine—hepatitis B	0.00379	0.00379	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Lamivudine—hepatitis B	0.00375	0.00375	CcSEcCtD
Glycopyrrolate—Skin disorder—Lamivudine—hepatitis B	0.00371	0.00371	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Lamivudine—hepatitis B	0.00369	0.00369	CcSEcCtD
Glycopyrrolate—Hypotension—Lamivudine—hepatitis B	0.00357	0.00357	CcSEcCtD
Glycopyrrolate—Insomnia—Lamivudine—hepatitis B	0.00345	0.00345	CcSEcCtD
Glycopyrrolate—Somnolence—Lamivudine—hepatitis B	0.0034	0.0034	CcSEcCtD
Glycopyrrolate—Dyspepsia—Lamivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.0033	0.0033	CcSEcCtD
Glycopyrrolate—Fatigue—Lamivudine—hepatitis B	0.00329	0.00329	CcSEcCtD
Glycopyrrolate—Pain—Lamivudine—hepatitis B	0.00327	0.00327	CcSEcCtD
Glycopyrrolate—Constipation—Lamivudine—hepatitis B	0.00327	0.00327	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Lamivudine—hepatitis B	0.00315	0.00315	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00312	0.00312	CcSEcCtD
Glycopyrrolate—Urticaria—Lamivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Glycopyrrolate—Abdominal pain—Lamivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Glycopyrrolate—Body temperature increased—Lamivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Lamivudine—hepatitis B	0.00281	0.00281	CcSEcCtD
Glycopyrrolate—Asthenia—Lamivudine—hepatitis B	0.00274	0.00274	CcSEcCtD
Glycopyrrolate—Pruritus—Lamivudine—hepatitis B	0.0027	0.0027	CcSEcCtD
Glycopyrrolate—Dizziness—Lamivudine—hepatitis B	0.00253	0.00253	CcSEcCtD
Glycopyrrolate—Vomiting—Lamivudine—hepatitis B	0.00243	0.00243	CcSEcCtD
Glycopyrrolate—Rash—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Glycopyrrolate—Dermatitis—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Glycopyrrolate—Headache—Lamivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Glycopyrrolate—Nausea—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
